Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-13

FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA granted approval of a supplemental application for Benazepril Hydrochloride from Aurobindo Pharma Limited (ANDA 078212).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benazepril hydrochloride (Benazepril hydrochloride)

Snippet

SUPPL AP for BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HYDROCHLORIDE)